These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 22173164)

  • 1. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
    Khan SA; Emadossadaty S; Ladep NG; Thomas HC; Elliott P; Taylor-Robinson SD; Toledano MB
    J Hepatol; 2012 Apr; 56(4):848-54. PubMed ID: 22173164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States.
    Welzel TM; McGlynn KA; Hsing AW; O'Brien TR; Pfeiffer RM
    J Natl Cancer Inst; 2006 Jun; 98(12):873-5. PubMed ID: 16788161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia.
    Shin HR; Oh JK; Masuyer E; Curado MP; Bouvard V; Fang Y; Wiangnon S; Sripa B; Hong ST
    Asian Pac J Cancer Prev; 2010; 11(5):1159-66. PubMed ID: 21198257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification.
    Tyson GL; Ilyas JA; Duan Z; Green LK; Younes M; El-Serag HB; Davila JA
    Dig Dis Sci; 2014 Dec; 59(12):3103-10. PubMed ID: 25204668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on incidence of intra- and extrahepatic cholangiocarcinoma in the United States.
    Matull WR; Khan SA; Pereira SP
    J Natl Cancer Inst; 2007 Mar; 99(5):407; author reply 407-8. PubMed ID: 17341733
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of changes in the topographic classification of Klatskin tumor on incidence of intra- and extrahepatic bile duct cancer: A population-based national cancer registry study.
    Kang MJ; Lim J; Han SS; Park HM; Kim SW; Won YJ; Park SJ
    J Hepatobiliary Pancreat Sci; 2021 Sep; 28(9):740-750. PubMed ID: 33615747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations.
    Ladep NG; Khan SA; Crossey MM; Thillainayagam AV; Taylor-Robinson SD; Toledano MB
    World J Gastroenterol; 2014 Feb; 20(6):1544-53. PubMed ID: 24587630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.
    Taylor-Robinson SD; Toledano MB; Arora S; Keegan TJ; Hargreaves S; Beck A; Khan SA; Elliott P; Thomas HC
    Gut; 2001 Jun; 48(6):816-20. PubMed ID: 11358902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholangiocarcinoma miscoding in hepatobiliary centres.
    Selvadurai S; Mann K; Mithra S; Bridgewater J; Malik H; Khan SA
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):635-639. PubMed ID: 33032867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological classification of liver and intrahepatic bile duct cancers in SEER registries.
    Altekruse SF; Devesa SS; Dickie LA; McGlynn KA; Kleiner DE
    J Registry Manag; 2011; 38(4):201-5. PubMed ID: 23270094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between anatomic variations of extrahepatic and intrahepatic bile ducts: Do look up!
    Renzulli M; Brandi N; Brocchi S; Balacchi C; Lanza C; Pettinari I; Stefanini B; Carrafiello G; Piscaglia F; Golfieri R; Marasco G
    J Anat; 2023 Apr; 242(4):683-694. PubMed ID: 36670522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using cancer registries to assess the accuracy of primary liver or intrahepatic bile duct cancer as the underlying cause of death, 1999-2010.
    Polednak AP
    J Registry Manag; 2013; 40(4):168-75. PubMed ID: 24625770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002.
    Jepsen P; Vilstrup H; Tarone RE; Friis S; Sørensen HT
    J Natl Cancer Inst; 2007 Jun; 99(11):895-7. PubMed ID: 17551150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time and deprivation trends in incidence of primary liver cancer subtypes in England.
    Konfortion J; Coupland VH; Kocher HM; Allum W; Grocock MJ; Jack RH
    J Eval Clin Pract; 2014 Aug; 20(4):498-504. PubMed ID: 24902884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of intrahepatic, perihilar, and distal cholangiocarcinoma in the French population.
    Al Mahjoub A; Bouvier V; Menahem B; Bazille C; Fohlen A; Alves A; Mulliri A; Launoy G; Lubrano J
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):678-684. PubMed ID: 30633038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathology of cholangiocarcinoma].
    Guedj N; Bedossa P; Paradis V
    Ann Pathol; 2010 Dec; 30(6):455-63. PubMed ID: 21167432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
    Welzel TM; Graubard BI; El-Serag HB; Shaib YH; Hsing AW; Davila JA; McGlynn KA
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1221-8. PubMed ID: 17689296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001.
    West J; Wood H; Logan RF; Quinn M; Aithal GP
    Br J Cancer; 2006 Jun; 94(11):1751-8. PubMed ID: 16736026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Klatskin Tumor in the Light of ICD-O-3: A Population-Based Clinical Outcome Study Involving 1,144 Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (2001-2012).
    Khan J; Ullah A; Matolo N; Waheed A; Nama N; Khan T; Tareen B; Khan Z; Singh SG; Cason FD
    Cureus; 2021 Oct; 13(10):e18941. PubMed ID: 34815893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.